Role of kinin and renal ANG II blockade in acute effects of ACE inhibitors in low-renin hypertension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 272, Issue 2 41-2, 1997, Pages

  Naitoh, Mareo ^a   Suzuki, Hiromichi ^a   Arakawa, Kouki ^a   Matsumoto, Akira ^a   Ichihara, Atsuhiro ^a   Matsuda, Hiroto ^a   Kubota, Eiji ^a   Murakami, Marohito ^a   Nakamoto, Hidetomo ^a   Saruta, Takao ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

bradykinin; deoxycorticosterone acetate salt hypertension; prostaglandin; renin angiotensin system; thromboxane

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMIDAPRILAT; KININ; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; HYPERTENSION; KIDNEY PLASMA FLOW; MEAN ARTERIAL PRESSURE; NATRIURESIS; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 33750865174     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.272.2.h679     Document Type: Article

References (40)

1. Ballermann, B. J., K. L. Skorecki, and B. M. Brenner. Reduced glomerular angiotensin II receptor density in early untreated diabetes mellitus in the rat. Am. J. Physiol. 247 (Renal Fluid Electrolyte Physiol. 16): F110-F116, 1984.
2. Bascands, J.-L., C. Pecher, S. Rouaud, C. Emond, J. L. Tack, M. J. Bastie, R. Burch, D. Regoli, and J.-P. Girolami. Evidence for existence of two distinct bradykinin receptors on rat mesangial cells. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F548-F556, 1993.
3. Baydoun, A. R., and B. Woodward. Effects of bradykinin in the rat isolated perfused heart: role of kinin receptors and endothelium-derived relaxing factor. Br. J. Pharmacol. 103: 1829-1833, 1991.
4. Baylis, C., K. Engels, L. Samsell, and P. Harton. Renal effects of acute endothelial-derived relaxing factor blockade are not mediated by angiotensin II. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F74-F78, 1993.
5. Bellucci, A., and B. M. Wilkes. Mechanism of sodium modulation of glomerular angiotensin receptors in the rat. J. Clin. Invest. 74: 1593-1600, 1984.
6. Chan, D. P., E. K. Sandok, L. L. Aarhus, D. M. Heublein, and J. C. Burnett, Jr. Renal-specific actions of angiotensin II receptor antagonism in the anesthetized dog. Am. J. Hypertens. 5: 354-360, 1992.
7. Cheng, H.-F., B. N. Becker, K. D. Burns, and R. C. Harris. Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule. J. Clin. Invest. 93: 2012-2019, 1995.
8. Chromczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium-PhOH-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
9. Cogan, M. G. Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension Dallas 15: 451-458, 1990.
10. Cogan, M. G., M.-H. Xie, F.-Y. Liu, P. C. Wong, and P. B. M. W. M. Timmermans. Effects of Dup 753 on proximal nephron and renal transport. Am. J. Hypertens. 4: 315S-320S, 1991.
11. Dunn, M. J., and V. L. Hood. Prostaglandins and the kidney. Am. J. Physiol. 233 (Renal Fluid Electrolyte Physiol. 2): F169-F184, 1977.
12. Dzau, V. J. Vascular renin-angiotensin: a possible autocrine or paracrine system on control of vascular function. J. Cardiovasc. Pharmacol. 6: S377-S382, 1984.
13. Dzau, V. J. Vascular renin-angiotensin system in hypertension. Am. J. Med. 84, Suppl. 4A: 4-8, 1988.
14. Fenoy, F. J., G. Scicli, O. Carretero, and R. J. Roman. Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril. Hypertension Dallas 17: 1038-1044, 1991.
15. Gavras, H., H. R. Brunner, G.A. Turini, G. R. Kershaw, C. P. Tifft, S. Cuttelod, I. Gavras, R. A. Vukovich, and D. N. McKinstry. Antihypertensive effect of the oral angiotensin converting enzyme inhibitor SQ14225 in man. N. Engl. J. Med. 298: 991-995, 1978.
16. Hajj-ali, A. F., and B. G. Zimmerman. Kinin contribution to renal vasodilator effect of captopril in rabbit. Hypertension Dallas 17: 504-509, 1991.
17. Hajj-ali, A. F., and B. G. Zimmerman. Nitric oxide participation in renal hemodynamic effect of angiotensin converting enzyme inhibitor lisinopril. Eur. J. Pharmacol. 212: 279-281, 1992.
18. Harris, P. J., and L. G. Navar. Tubular transport responses to angiotensin. Am. J. Physiol. 248 (Renal Fluid Electrolyte Physiol. 17): F621-F630, 1985.
19. Hollenberg, N. K., L. G. Meggs, G. H. Williams, J. Katz, J. D. Garnie, and D. P. Harrington. Sodium intake and renal responses to captopril in normal man and in essential hypertension. Kidney Int. 20: 240-245, 1981.
20. Lammek, B., Y.-X. Wang, I. Gavras, and H. Gavras. A new highly potent antagonist of bradykinin. Peptides 11: 1041-1043, 1990.
21. Liu, F.-Y., and M. G. Cogan. Angiotensin II stimulation of hydrogen ion secretion in the rat early proximal tubule. Modes of action, mechanism, and kinetics. J. Clin. Invest. 82: 601-607, 1988.
22. Liu, F.-Y., and M. G. Cogan. Angiotensin II stimulates early proximal bicarbonate absorption in the rat by decreasing cyclic adenosine monophosphate. J. Clin. Invest. 84: 83-91, 1989.
23. Melby, J. C. Angiotensin-converting enzyme in cardiovascular and adrenal tissues and implication for successful blood pressure management. Am. J. Cardiol. 69: 2C-7C, 1992.
24. Mujais, S. K., S. Kauffman, and A. I. Katz. Angiotensin II binding sites in individual segments of the rat nephron. J. Clin. Invest. 77: 315-318, 1986.
25. Naito, J., H. Komatsu, A. Ujiie, S. Hamano, T. Kubota, and M. Tsuboshima. Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets. Eur. J. Pharmacol. 91: 41-48, 1983.
26. Naitoh, M., H. Suzuki, M. Murakami, A, Matsumoto, K. Arakawa, A. Ichihara, H. Nakamoto, K. Oka, Y. Yamamura, and T. Saruta. Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H2245-H2254, 1994.
27. Nakagawa, M., and A. Nasjletti. Plasma kinin concentration in deoxycorticosterone-salt hypertension. Hypertension Dallas 11: 411-415, 1988.
28. Nakagawa, M., J. M. Stewart, R. J. Vavrek, and A. Nasjletti. Effects of kinin antagonist on renal function in rats. Am. J. Physiol. 258 (Renal Fluid Electrolyte Physiol. 27): F643-F648, 1990.
29. Nasjletti, A., J. C. McGiff, and J. Colina-Chourio. Interrelations of the renal kallikrein-kinin system and renal prostaglandins in the conscious rat. Influence of mineralocorticoids. Circ. Res. 43: 799-807, 1978.
30. Roman, R. J., M. L. Kaldunski, D. L. Mattson, M. Mistry, and A. Nasjletti. Influence of eicosanoids on renal function of DOCA-salt hypertensive rats. Hypertension Dallas 12: 287-294, 1988.
31. 2, water, and sodium excretion. Hypertension Dallas 25: 1008-1013, 1995.
32. Sasaguri, M., M. Ideishi, A. Kinoshita, and K. Arakawa. Differential inhibition of bradykinin hydrolysis by four ACE inhibitors: a possible explanation for differences in induced coughing. Hypertens. Res. 17: 253-258, 1994.
33. Schrör, K. Converting enzyme inhibitors and the interaction between kinins and eicosanoids. J. Cardiovasc. Pharmacol. 15, Suppl. 6: S60-S68, 1990.
34. Steiner, R. W., B. J. Tucker, and R. C. Blantz. Glomerular hemodynamics in rats with chronic sodium depletion. Effects of saralasin. J. Clin. Invest. 64: 503-512, 1979.
35. Sugaya, T., S. Minobe, T. Taniguchi, Y. Hashimoto, M. Kubo, and T. Watanabe. Studies on angiotensin I converting enzyme inhibitory effect of imidapril. Fol. Pharmacol. Jpn. 100: 39-45, 1992.
36. Swartz, S. L., G. H. Williams, and N. K. Hollenberg. Captopril-induced changes in prostaglandin production. J. Clin. Invest. 65: 1257-1264, 1980.
37. Terada, Y., K. Tomita, H. Nonoguchi, and F. Marumo. PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney. Kidney Int. 43: 1251-1259, 1993.
38. Wilson, S. K., D. R. Lynch, and P. W. Ladenson. Angiotensin II and atrial natriuretic factor-binding sites in various tissues in hypertension: comparative receptor localization and changes in different hypertension models in the rat. Endocrinology 124: 2799-2808, 1989.
39. Wong, P. C., T. Bradford Barnes, A. T. Chiu, D. D. Christ, J. V. Duncia, W. F. Herblin, and P. B. M. W. M. Timmermans. Losartan (Dup 753), an orally active nonpeptide angiotensin II receptor antagonist. Cardiovasc. Drug Rev. 9: 317-339, 1991.
40. Wong, P. C., W. A. Price, Jr., A. T. Chiu, J. V. Duncia, D. J. Carini, R. R. Wexler, A. L. Johnson, and P. B. M. W. M. Timmermans. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of Dup 753, an orally antihypertensive agent. J. Pharmacol. Exp. Ther. 255: 211-217, 1990.